Urticaria Activity Score – Prof. Marcus Maurer

Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria – a systematic review for the EAACI biologicals guidelines

412.

Agache, I.⁺, Rocha, C., Pereira, A., Song, Y., Alonso-Coello, P., Solà, I., Beltran, J., Posso, M., Akdis, C., Akdis, M., Brockow, K., Chivato, T., del Giacco, S., Eiwegger, T., Eyerich, K., Giménez-Arnau, A., Gutermuth, J., Guttman-Yassky, E., Maurer, M., Ogg, G., Ong, P., O’Mahony, L., Schwarze, J., Werfel, T., Canelo-Aybar, C., Palomares, O., and Jutel, M.: Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria – a systematic review for the EAACI biologicals guidelines. Allergy 2021: 76; 59-70. IF: 14.71

o.412

Comparison and interpretability of the available urticaria activity scores

291	Hawro, T., Ohanyan, T., Schoepke, N., Metz, M., Peveling-Oberhag, A., Staubach, P., Maurer, M. and Weller, K.+: Comparison and interpretability of the available urticaria activity scores. Allergy 2018: 73; 251-255. IF: 6.77

Diagnosis of urticaria

74.	Schoepke, N., Doumoulakis, G., and Maurer, M.: Diagnosis of urticaria. Ind. J. Dermatology 2013: 58; 211-218. IF: N/A

Instrumente zur Erfassung von Krankheitsaktivität, Krankheitskontrolle und Lebensqualitätsbeeinträchtigung bei Patienten mit chronischer Urtikaria und Angioödemen

104.

Weller, K., Peveling-Oberhag, A., Altrichter, S., Schoepke, N., Abajian, M., Zuberbier, T., Staubach, P., and Maurer, M.: Instrumente zur Erfassung von Krankheitsaktivität, Krankheitskontrolle und Lebensqualitätsbeeinträchtigung bei Patienten mit chronischer Urtikaria und Angioödemen. Allergologie 2016: 39; 6-15. IF: 0.31

r.104

IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria. J

325	Schmetzer, O.+, Lakin, E., Topal, F. A., Preusse, P., Freier, D., Church, M. K., and Maurer, M.: IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria. J. Allergy Clin. Immunol. 2018: 142; 876-882. IF: 14.11)

The urticaria activity score – validity, reliability, and responsiveness

322	Hawro, T., Ohanyan, T., Schoepke, N., Metz, M., Peveling-Oberhag, A., Staubach, P., Maurer, M. and Weller, K.+: The urticaria activity score – validity, reliability, and responsiveness. J. Allergy Clin. Immunol. Pract. 2018: 6; 1185-1190. IF: 7.55

Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria

172

Koti, I., Weller, K., Makris, M., Tiligada, E., Psaltopoulou, T., Papageorgiou, C., Baiardini, I., Panagiotakos, D., Braido, F., and Maurer, M.+: Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria. Dermatology 2013: 226; 371-379. IF: 1.68